A first step beyond traditional boundaries: destination therapy with the SynCardia total artificial heart

Interact Cardiovasc Thorac Surg. 2014 Jun;18(6):855-6. doi: 10.1093/icvts/ivu065. Epub 2014 Mar 14.

Abstract

The SynCardia total artificial heart is currently used as a bridge to transplantation therapy in cases of irreversible, acute or chronic, biventricular heart failure. We describe the implementation of this technology in the context of destination therapy in a patient with an end-stage heart failure on grounds of primary amyloidosis.

Keywords: Amyloidosis; Artificial heart; Cardiac failure.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amyloidosis / complications*
  • Amyloidosis / diagnosis
  • Amyloidosis / physiopathology
  • Cardiomyopathies / complications*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / physiopathology
  • Heart Failure / diagnosis
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart, Artificial*
  • Hemodynamics
  • Humans
  • Immunoglobulin Light-chain Amyloidosis
  • Male
  • Prosthesis Design
  • Time Factors
  • Treatment Outcome
  • Ventricular Function